Patrick F. Williams - 15 May 2026 Form 4 Insider Report for NeuroPace Inc (NPCE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 May 2026, 16:51:39 UTC
Prior SEC filing
24 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leah Akin, Attorney-in-Fact

Key filing fact

Patrick F. Williams filed Form 4 for NeuroPace Inc (NPCE) on 19 May 2026.

Key facts

  • This page summarizes Patrick F. Williams's Form 4 filing for NeuroPace Inc (NPCE).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 May 2026, 16:51.

Change

  • Previous filing in this sequence was filed on 24 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001562229 Primary reporting owner

Williams Patrick F.

Relationship
Chief Financial Officer
Address
C/O NEUROPACE, INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW
Signature
/s/ Leah Akin, Attorney-in-Fact
Signature date
19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NPCE transaction

Common Stock

Award

Transaction value
Shares
+16,820
Change %
+32%
Price
$0.000000*
Shares after
68,670
Date
15 May 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NPCE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+44,800
Change %
Price
$0.000000*
Shares after
44,800
Date
15 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
44,800
Exercise price
$15.36
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.

Footnote F2

25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .